Smith Group Asset Management’s Spectrum Pharmaceuticals Inc SPPI Stock Holding History

Smith Group Asset Management’s Portfolio SPPI Stock Details SPPI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	–	Sell	-3,250	Closed	-$28K	–	456
2019 Q2	$28K	Hold	3,250	–	–	﹤0.01%	321
2019 Q1	$35K	Sell	3,250 -8,590	-73%	-$92K	﹤0.01%	330
2018 Q4	$104K	Hold	11,840	–	–	﹤0.01%	280
2018 Q3	$199K	Buy	+11,840	New	+$256K	0.01%	249
2015 Q1	–	Sell	-120,950	Closed	-$838K	–	459
2014 Q4	$838K	Buy	+120,950	New	+$889K	0.03%	189

Other funds holding SPPI

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

ACH

ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Smith Group Asset Management's SPPI Position: Q3 2019 in Review

Smith Group Asset Management sold out of Spectrum Pharmaceuticals Inc (SPPI) in Q3 2019, closing a stake of 3,250 shares — an estimated $28K sold.

Smith Group Asset Management first reported a position in SPPI in Q4 2014 and held it in 5 quarters. The position peaked at $838K in Q4 2014. 167 funds tracked by Wall St. Rank hold SPPI as of Q3 2019.

Smith Group Asset Management reported no remaining Spectrum Pharmaceuticals Inc position as of Q3 2019 after selling out during the quarter.
Smith Group Asset Management sold 3,250 Spectrum Pharmaceuticals Inc shares in Q3 2019, an estimated $28K.
Smith Group Asset Management first reported a position in Spectrum Pharmaceuticals Inc in Q4 2014 and held it in 5 quarters.
Smith Group Asset Management's Spectrum Pharmaceuticals Inc position peaked at $838K in Q4 2014.
167 funds tracked by Wall St. Rank held Spectrum Pharmaceuticals Inc as of Q3 2019.

Based on Smith Group Asset Management's 13F filing for Q3 2019, filed 12 Nov 2019.